YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Fagron (ENXTBR:FAGR) reports strong revenue growth alongside the completion of an acquisition, including Injeplast in Brazil. Management highlights progress on integrating acquired businesses, with Injeplast seen as important for the Brazi…
Investing.com -- Fagron on Thursday reported third-quarter revenue in line with analyst expectations as an industry-wide IV bag recall hit its North American compounding business, and it kept its full-year guidance. Before you buy NVIDIA:…
Fagron NV Regulated information – inside information Nazareth-De Pinte (Belgium)/Rotterdam (The Netherlands), 8 October 2026 – 7:00 AM CET Fagron delivers strong 23.2% revenue growth in the third quarter to €281.3 million and confirms FY g…
Fagron NV Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 29 September 2026 – 6 PM CET Disclosure of a transparency notification from BlackRock, Inc. Pursuant to the Belgian act of 2 May 2007 on the disclosure of majo…
Fagron NV Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 21 March 2026 – 7PM CET Fagron increases share capital through exercise subscription rights Fagron announces that as a result of the exercise of subscription r…
This article first appeared on GuruFocus. Revenue: EUR552.5 million in H1 2026, up 16% on a reported basis, with 3.1% organic growth at CER (7% when normalizing the GLP-1 effect). Adjusted EBITDA: EUR107 million, up 12.7% year over year, w…
Fagron NV Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 30 July 2026 – 7:00 AM CET Fagron delivers strong H1 2026 performance with 16% topline growth and reiterates FY 2026 guidance Fagron, the leading global player…
Fagron NV Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 3 June 2026 – 6 PM CET Disclosure of transparency notification from FMR LLC Pursuant to the Belgian Act of 2 May 2007 on the disclosure of major shareholdings…
Fagron NV Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 18 May 2026 – 6 PM CET Disclosure of transparency notifications from BlackRock, Inc. Pursuant to the Belgian act of 2 May 2007 on the disclosure of major share…
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Fagron (ENXTBR:FAGR) shareholders approved all resolutions at the A…
Fagron NV Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 11 May 2026 – 6PM CET Fagron shareholders approve all proposed resolutions at the General Meetings Fagron, the leading global player in pharmaceutical compound…
Fagron NV Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 30 April 2026 – 6 PM CET Disclosure of transparency notification from BlackRock, Inc. Pursuant to the Belgian act of 2 May 2007 on the disclosure of major shar…
Fagron NV Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 28 April 2026 – 6 PM CET Disclosure of transparency notification from BlackRock, Inc. Pursuant to the Belgian act of 2 May 2007 on the disclosure of major shar…
Fagron NV Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 16 April 2026 – 6 PM CET Disclosure of transparency notifications from BlackRock, Inc. Pursuant to the Belgian act of 2 May 2007 on the disclosure of major sha…
Amy Jones - Business Leader, Brands & Essentials at Fagron North America / Marc Joiner - Co Founder of Pete Pharma / Andrew Allan - Vice President, Sales at Fagron North America PHOENIX, April 16, 2026--(BUSINESS WIRE)--Pete Pharma, a phar…
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Fagron’s analyst story has just been refreshed with a new price target of €29, up from €28, which p…
Fagron NV Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 10 April 2026 – 7 AM CEST Fagron convenes Ordinary and Extraordinary General Meeting on 11 May 2026 Fagron NV invites its shareholders and holders of subscript…
Fagron NV Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 9 April 2026 – 7:00 AM CET Fagron reports solid first-quarter revenue of €263 million, reflecting 10% topline growth Fagron, the leading global player in pharm…
Fagron NV Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 31 March 2026 – 7PM CET Fagron increases share capital through exercise subscription rights Fagron announces that as a result of the exercise of subscription r…
Fagron NV Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 20 March 2026 – 6 PM CET Disclosure of a transparency notification from Aberdeen Group plc Pursuant to the Belgian act of 2 May 2007 on the disclosure of major…
Fagron NV Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 13 March 2026 – 6 PM CET Disclosure of a transparency notification from Mawer Investment Management Ltd Pursuant to the Belgian act of 2 May 2007 on the disclo…
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Fagron (ENXTBR:FAGR) has completed the acquisition of Vepakum, expanding its presence in Latin America. The deal adds n…
Fagron NV Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 6 March 2026 7AM CET Fagron publishes its Annual Report 2025 Fagron, the leading global player in pharmaceutical compounding, today publishes its Annual Report…
Fagron NV Regulated information – inside information Nazareth (Belgium)/Rotterdam (The Netherlands), 3 March 2026 – 7:00AM Fagron completes acquisition of Vepakum Fagron, the leading global player in pharmaceutical compounding, announces t…
Fagron NV Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 27 02 2026 – 6PM CET Disclosure of a transparency notification from AOC Pharma S.à r.l. Pursuant to the Belgian Act of 2 May 2007 on the disclosure of major sh…
Fagron NV Regulated information – inside information Nazareth (Belgium)/Rotterdam (The Netherlands), 26 February 2026 – 6:30PM Fagron completes strategic acquisition of Pharmavit Europe, strengthening its leadership in high‑growth nutraceu…
This article first appeared on GuruFocus. Revenue: EUR952.2 million, a 9.2% increase on a reported basis. Organic Revenue Growth: 9.1% at constant exchange rates. Profitability: EUR193 million, a 10.9% increase, with a margin of 20.3%. Gro…
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Fagron (ENXTBR:FAGR) has drawn investor interest after recent share…
Fagron NV Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 12 February 2026 – 7AM CET Fagron continues its outstanding performance in FY 2025 with 9.2% topline growth and 10.9% increase in REBITDA Fagron, the leading g…
Fagron NV Regulated information - inside information Nazareth (Belgium)/Rotterdam (The Netherlands), 5 February 2026 Fagron obtains regulatory clearance for the acquisition of Vepakum in Brazil and completes the acquisition of Magilab in H…
Fagron NV Regulated information - inside information Nazareth (Belgium)/Rotterdam (The Netherlands), 12 January 2026 – 7:00 AM CET Fagron announces the completion of the acquisition of University Compounding Pharmacy in North America Fagro…
Fagron NV Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 09 January 2026 – 5:40 PM CET Disclosure of notification received from BNP Paribas Pursuant to the Belgian law of 2 May 2007 regarding the disclosure of major…
Fagron NV Regulated information - inside information Nazareth (Belgium)/Rotterdam (The Netherlands), 6 January 2026 – 7:00 AM CET Fagron announces the completion of Purifarma Fagron, the leading global player in pharmaceutical compounding,…
Wondering if Fagron at €21.30 is still a smart buy after its run up, or if the easy money has already been made? This article will walk through what the current price really implies. The stock has climbed 3.4% over the last week, 2.9% over…
Fagron NV Regulated information - inside information Nazareth (Belgium)/Rotterdam (The Netherlands), 19 December 2025 – 7:00 AM CET Fagron accelerates global expansion with two strategic acquisitions and a key North American licensing mile…
(RTTNews) - Fagron (FAGR.BR) announced acquisitions of a book of business from Amara, and Magilab. Amara is a player in the compounding sector, operating raw materials in Poland. Magilab is a specialized player in the hospital pharmacy seg…